A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia

Health Policy

Volumn 95, Issue 2-3, 2010, Pages 229-235

  Chua, Gin Nie ^a   Hassali, Mohamed Azmi ^a   Shafie, Asrul Akmal ^a   Awaisu, Ahmed ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

General practitioners; Generic medicines; Knowledge; Perception; Physicians

Indexed keywords

GENERIC DRUG;

ADULT; AGED; ARTICLE; BIOEQUIVALENCE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MALAYSIA; MALE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; PROFESSIONAL MISCONDUCT; QUESTIONNAIRE; SOCIOECONOMICS;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DRUG AND NARCOTIC CONTROL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRUGS, GENERIC; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES; SAFETY; THERAPEUTIC EQUIVALENCY;

EID: 77950937059     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2009.11.019     Document Type: Article

References (34)

1. King D.R., Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croatian Medical Journal 2002, 43:462-469.
2. Abdool Karim S.S., Pillai G., Ziqubu-Page T.T., Cassimjee M.H., Morar M. Potential savings from generic prescribing an generic substitution in South Africa. Health Policy and Planning 1996, 11:198-205.
3. Kanavos P. Do generics offer significant savings to the UK National Health Service?. Current Medical Research and Opinion 2007, 23:105-116.
4. Key facts-contribution of generic medicines to the UK. British Generic Manufacturers Association.
5. Goh A., Faridah A., Rosminah M., Nour Hanah O., Noor Aini Z Expenditure on medicines in Malaysia: estimates from Malaysian Statistics on Medicines 2005. Proceedings of the 7th MOH-AAM Scientific Meeting 2007.
6. Malaysia National Health Accounts Policy Dialogue Proceedings 2006. Planning & development division 2007, Ministry of Health Malaysia. Malaysia MoH (Ed.).
7. Malaysia-Out-of-pocket expenditure as percentage on private expenditure on health 1995-2006.WHO Statistical Information System.
8. Chong C., Bahari B., Hassali M. Generic subtitution in community pharmacies of Penang area. Malaysian Journal of Pharmaceutical Sciences 2005, 3:74
9. Drug registration guidance document (Malaysia) 2009, National Pharmaceutical Control Bureau, Ministry of Health Malaysia, Available at http://www.bpfk.gov.my/ [accessed on 20th May 2009].
10. Tham L.H., Yahya I. Malaysia pharmaceutical industry outlook 2008 2009, Available at http://www.frost.com/prod/servlet/market-insight-top.pag?docid=126369590 [accessed on 10th May 2009].
11. Malaysian industrial development authority. Industries in Malaysia: pharmaceutical industry. Available at [accessed on 26th May 2009]. http://www.mida.gov.my/.
12. Azmi I.M., Alavi R. TRIPS, patents, technology transfer, foreign direct investment and the pharmaceutical industry in Malaysia'. Journal of World Intellectual Property 2001, 4(6):947-976.
13. Babar Z., Izham M.I.M., Bukhari N. Medicine utilization and pricing: the findings of a household survey in Malaysia. Journal of Generic Medicine 2005, 3.
14. Babar Z., Awaisu A. Evaluating community pharmacists' perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. Journal of Generic Medicines 2008, 5:315-330.
15. Parsons J., Warnecke R., Czaja R., Barnsley J., Kaluzny A. Factors associated with response rates in a national survey of primary care physicians. Evaluation Review 1994, 18:756.
16. Kellerman S.E., Herold J. Physician response to surveys-a review of literature. American Journal of Preventive Medicine 2001, 20(1):61-67.
17. VanGeest J., Johnson T., Welch V. Methodologies for improving response rates in surveys of physicians: a systematic review. Evaluation & the Health Professions 2007, 30:303.
18. Banahan B., Kolassa E. A physician survey on generic drugs and substitution of critical dose medications. Archives of Internal Medicine 1997, 157:2080-2088.
19. Hassali M., Kong D., Stewart K. Generic medicines: perceptions of general practitioners in Melbourne, Australia. Journal of Generic Medicines 2006, 3:214-225.
20. McGettigan P., McManus J., O'Shea B., Chan R., Feely J. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns. Irish Medical Journal 1997, 90(4):146.
21. Heikkila R., Mäntyselkä P., Hartikainen-Herranen K., Ahonen R. Customers'and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy 2007, 82:366-374.
22. Paraponaris A., Verger P., Desquins B., Villani P., Bouvenot G., Rochaix L., et al. Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy 2004, 70:23-32.
23. Malaysian guidelines for the conduct of bioavailability and bioequivalence studies 2000, Ministry of Health Malaysia.
24. WHO medicines strategy 2000-2003. WHO policy perspective on medicines 2000, WHO.
25. Beecroft G. Generic drug policy in Australia: a community pharmacy perspective. Australia and New Zealand Health Policy 2007, 4:7.
26. Malaysia national medicine policy 2006, Ministry of Health.
27. Thomas R., Vitry A. Consumers' perception of generic medicines in community pharmacies in Malaysia. Southern Medicinal Review 2009, 2(2):20-23.
28. Valles J., Barreiro M., Cereza G., Ferro J., Mart nez M., Escriba J., et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003, 65:269-275.
29. Guidance note no. 25: best practice guidance on labelling and packaging of medicines 2003, Medicines and Healthcare products Regulatory Agency, London.
30. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say?. CMAJ: Canadian Medical Association Journal 1993, 149:1401.
31. Wazana A. Physicians and the pharmaceutical industry is a gift ever just a gift?. JAMA 2000, 283:373-380.
32. Alghasham A. Generic drug prescribing in central Saudi Arabia: perceptions and attitudes of physicians. Annals of Saudi Medicine 2009, 29:24-29.
33. Meadows M. Greater access to generic drugs: new FDA initiatives to improve drug reviews and reduce legal Loopholes. FDA Consumer 2003, 37:12-18.
34. Gossell-Williams M. Generic substitutions: a 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Medical Journal 2007, 56:458-463.